Related Articles
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy
A phase II study of bromocriptine in patients with androgen-independent prostate cancer.
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: A phase II study
Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer
Phase Ⅱ trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer